Literature DB >> 16882706

Suppression of hepcidin during anemia requires erythropoietic activity.

Mihwa Pak1, Miguel A Lopez, Victroia Gabayan, Tomas Ganz, Seth Rivera.   

Abstract

Hepcidin, the principal iron regulatory hormone, regulates the absorption of iron from the diet and the mobilization of iron from stores. Previous studies indicated that hepcidin is suppressed during anemia, a response that would appropriately increase the absorption of iron and its release from stores. Indeed, in the mouse model, hepcidin-1 was suppressed after phlebotomy or erythropoietin administration but the suppression was reversed by inhibitors of erythropoiesis. The suppression of hepcidin necessary to match iron supply to erythropoietic demand thus requires increased erythropoiesis and is not directly mediated by anemia, tissue hypoxia, or erythropoietin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882706      PMCID: PMC1895477          DOI: 10.1182/blood-2006-06-028787

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Serum transferrin receptor as a new index of erythropoiesis.

Authors:  Y Kohgo; Y Niitsu; H Kondo; J Kato; N Tsushima; K Sasaki; M Hirayama; T Numata; T Nishisato; I Urushizaki
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

Review 2.  Soluble transferrin receptor for the evaluation of erythropoiesis and iron status.

Authors:  Yves Beguin
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

3.  Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload.

Authors:  Gennady Ilyin; Brice Courselaud; Marie Bérengère Troadec; Christelle Pigeon; Mehdi Alizadeh; Patricia Leroyer; Pierre Brissot; Olivier Loréal
Journal:  FEBS Lett       Date:  2003-05-08       Impact factor: 4.124

4.  Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice.

Authors:  Andrzej Mazur; Christine Feillet-Coudray; Béatrice Romier; Dominique Bayle; Elyett Gueux; Marc Ruivard; Charles Coudray; Yves Rayssiguier
Journal:  Metabolism       Date:  2003-10       Impact factor: 8.694

5.  Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression.

Authors:  Carola A Neumann; Daniela S Krause; Christopher V Carman; Shampa Das; Devendra P Dubey; Jennifer L Abraham; Roderick T Bronson; Yuko Fujiwara; Stuart H Orkin; Richard A Van Etten
Journal:  Nature       Date:  2003-07-31       Impact factor: 49.962

6.  Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate.

Authors:  Philippe Gervois; Robert Kleemann; Antoine Pilon; Frédéric Percevault; Wolfgang Koenig; Bart Staels; Teake Kooistra
Journal:  J Biol Chem       Date:  2004-02-05       Impact factor: 5.157

7.  An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice.

Authors:  Cindy N Roy; Angel O Custodio; Jos de Graaf; Susanne Schneider; Imo Akpan; Lynne K Montross; Mayka Sanchez; Alessandro Gaudino; Matthias W Hentze; Nancy C Andrews; Martina U Muckenthaler
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

8.  Hepcidin, a new iron regulatory peptide.

Authors:  Gaël Nicolas; Lydie Viatte; Myriam Bennoun; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  Blood Cells Mol Dis       Date:  2002 Nov-Dec       Impact factor: 3.039

9.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

Authors:  Elizabeta Nemeth; Seth Rivera; Victoria Gabayan; Charlotte Keller; Sarah Taudorf; Bente K Pedersen; Tomas Ganz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  Microanalysis of non-heme iron in animal tissues.

Authors:  Charles J Rebouche; Cari L Wilcox; John A Widness
Journal:  J Biochem Biophys Methods       Date:  2004-03-31
View more
  183 in total

1.  Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women.

Authors:  Colin I Cercamondi; Ines M Egli; Ella Ahouandjinou; Romain Dossa; Christophe Zeder; Lamidhi Salami; Harold Tjalsma; Erwin Wiegerinck; Toshihiko Tanno; Richard F Hurrell; Joseph Hounhouigan; Michael B Zimmermann
Journal:  Am J Clin Nutr       Date:  2010-10-06       Impact factor: 7.045

2.  Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.

Authors:  Yoshibumi Kaneko; Hiroaki Miyajima; Alberto Piperno; Naohisa Tomosugi; Hisao Hayashi; Natsuko Morotomi; Ken-ichi Tsuchida; Takaaki Ikeda; Akihisa Ishikawa; Yusuke Ota; Shinya Wakusawa; Kentaro Yoshioka; Satoshi Kono; Sara Pelucchi; Ai Hattori; Yasuaki Tatsumi; Toshihide Okada; Masakazu Yamagishi
Journal:  J Gastroenterol       Date:  2010-06-09       Impact factor: 7.527

3.  Interrelationships between tissue iron status and erythropoiesis during postweaning development following neonatal iron deficiency in rats.

Authors:  Narasimha V Hegde; Erica L Unger; Gordon L Jensen; Pamela A Hankey; Robert F Paulson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-30       Impact factor: 4.052

Review 4.  Hepcidin and iron homeostasis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Biochim Biophys Acta       Date:  2012-01-26

Review 5.  Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.

Authors:  Sara Gardenghi; Robert W Grady; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2010-10-15       Impact factor: 3.722

6.  Characterization of erythropoietin and hepcidin in the regulation of persistent injury-associated anemia.

Authors:  Ines G Alamo; Kolenkode B Kannan; Michael A Smith; Philip A Efron; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2016-10       Impact factor: 3.313

7.  Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.

Authors:  Chia-Yu Wang; Amanda B Core; Susanna Canali; Kimberly B Zumbrennen-Bullough; Sinan Ozer; Lieve Umans; An Zwijsen; Jodie L Babitt
Journal:  Blood       Date:  2017-04-24       Impact factor: 22.113

Review 8.  The pathophysiology and pharmacology of hepcidin.

Authors:  Piotr Ruchala; Elizabeta Nemeth
Journal:  Trends Pharmacol Sci       Date:  2014-02-17       Impact factor: 14.819

9.  Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.

Authors:  Jason S Troutt; Anthony M Butterfield; Robert J Konrad
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

10.  Iron loading increases ferroportin heterogeneous nuclear RNA and mRNA levels in murine J774 macrophages.

Authors:  Fikret Aydemir; Supak Jenkitkasemwong; Sukru Gulec; Mitchell D Knutson
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.